{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:08:32Z","timestamp":1793405312837,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ejmg.2023.104734","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T21:27:20Z","timestamp":1677706040000},"page":"104734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["French cohort of children and adolescents with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas: CASSIOPEA study"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8194-457X","authenticated-orcid":false,"given":"Pierre","family":"Wolkenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Chaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Entz Werle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Amini-Adle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Barbarot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Miled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmg.2023.104734_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13023-020-1310-3","article-title":"Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966","volume":"15","author":"Bergqvist","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.ejmg.2023.104734_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/BPO.0b013e31820cad77","article-title":"Resection of plexiform neurofibromas in children with neurofibromatosis type 1","volume":"31","author":"Canavese","year":"2011","journal-title":"J. Pediatr. Orthop."},{"issue":"6","key":"10.1016\/j.ejmg.2023.104734_bib3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/ajmg.a.62691","article-title":"Location, symptoms, and management of plexiform neurofibromas in 127 children with neurofibromatosis 1, attending the National Complex Neurofibromatosis 1 service, 2018-2019","volume":"188","author":"Collins-Sawaragi","year":"2022","journal-title":"Am. J. Med. Genet. A"},{"issue":"7","key":"10.1016\/j.ejmg.2023.104734_bib4","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/ajmg.a.61627","article-title":"Clinical characteristics and quality of life, depression, and anxiety in adults with neurofibromatosis type 1: a nationwide study","volume":"182","author":"Doser","year":"2020","journal-title":"Am. J. Med. Genet. A"},{"issue":"1","key":"10.1016\/j.ejmg.2023.104734_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40487-022-00213-4","article-title":"Clinical characteristics and management of children and adults with neurofibromatosis type 1 and plexiform neurofibromas in Denmark: a nationwide study","volume":"11","author":"Ejerskov","year":"2022","journal-title":"Oncol. Ther."},{"issue":"5","key":"10.1016\/j.ejmg.2023.104734_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.ejmg.2023.104734_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"issue":"5","key":"10.1016\/j.ejmg.2023.104734_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s10897-018-0229-5","article-title":"Health survey of adults with neurofibromatosis 1 compared to population study controls","volume":"27","author":"Fjermestad","year":"2018","journal-title":"J. Genet. Counsel."},{"issue":"8","key":"10.1016\/j.ejmg.2023.104734_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/088307380201700802","article-title":"Neurofibromatosis 1: clinical manifestations and diagnostic criteria","volume":"17","author":"Friedman","year":"2002","journal-title":"J. Child Neurol."},{"issue":"12","key":"10.1016\/j.ejmg.2023.104734_bib10","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/neuonc\/noy067","article-title":"Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1","volume":"20","author":"Gross","year":"2018","journal-title":"Neuro Oncol."},{"issue":"15","key":"10.1016\/j.ejmg.2023.104734_bib11","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmg.2023.104734_bib12","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"Suppl. 1","key":"10.1016\/j.ejmg.2023.104734_bib13","first-page":"i141","article-title":"Quality of life in patients with neurofibromatosis type 1 and 2 in Canada","volume":"2","author":"Hamoy-Jimenez","year":"2020","journal-title":"Neurooncol. Adv."},{"issue":"1","key":"10.1016\/j.ejmg.2023.104734_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","article-title":"Clinical and genetic aspects of neurofibromatosis 1","volume":"12","author":"Jett","year":"2010","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ejmg.2023.104734_bib15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/theoncologist.5-6-477","article-title":"Malignancy in neurofibromatosis type 1","volume":"5","author":"Korf","year":"2000","journal-title":"Oncol."},{"issue":"3","key":"10.1016\/j.ejmg.2023.104734_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00234-005-0033-4","article-title":"MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1","volume":"48","author":"Mautner","year":"2006","journal-title":"Neuroradiology"},{"issue":"4","key":"10.1016\/j.ejmg.2023.104734_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1215\/15228517-2008-011","article-title":"Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1","volume":"10","author":"Mautner","year":"2008","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.ejmg.2023.104734_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0022-3476(97)70092-1","article-title":"Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994","volume":"131","author":"Needle","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmg.2023.104734_bib20","series-title":"Protocole National de Diagnostic et de Soins (PNDS) Neurofibromatose 1","author":"Neurofibromatoses","year":"2021"},{"key":"10.1016\/j.ejmg.2023.104734_bib21","first-page":"1","volume":"vol. 6","year":"1987"},{"key":"10.1016\/j.ejmg.2023.104734_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1750-1172-7-75","article-title":"Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1","volume":"7","author":"Nguyen","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ejmg.2023.104734_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/gim.2013.30","article-title":"Growth behavior of plexiform neurofibromas after surgery","volume":"15","author":"Nguyen","year":"2013","journal-title":"Genet. Med."},{"issue":"3\u20134","key":"10.1016\/j.ejmg.2023.104734_bib24","first-page":"22","article-title":"Neurofibromatosis 1 prevalence in children aged 9-11 years, Pinar del R\u00edo Province, Cuba","volume":"16","author":"Orraca","year":"2014","journal-title":"MEDICC Rev."},{"issue":"3","key":"10.1016\/j.ejmg.2023.104734_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpeds.2011.08.051","article-title":"Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1","volume":"160","author":"Prada","year":"2012","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ejmg.2023.104734_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.spen.2006.01.005","article-title":"Clinical manifestations and management of neurofibromatosis type 1","volume":"13","author":"Tonsgard","year":"2006","journal-title":"Semin. Pediatr. Neurol."},{"issue":"6","key":"10.1016\/j.ejmg.2023.104734_bib27","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1212\/WNL.50.6.1755","article-title":"CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions","volume":"50","author":"Tonsgard","year":"1998","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ejmg.2023.104734_bib28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/jid.2014.465","article-title":"Incidence and mortality of neurofibromatosis: a total population study in Finland","volume":"135","author":"Uusitalo","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"17","key":"10.1016\/j.ejmg.2023.104734_bib29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with neurofibromatosis type 1","volume":"34","author":"Uusitalo","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ejmg.2023.104734_bib30","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00381-022-05513-8","article-title":"Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA","volume":"38","author":"Yang","year":"2022","journal-title":"Child\u2019s Nerv. Syst."},{"issue":"15","key":"10.1016\/j.ejmg.2023.104734_bib31","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.18632\/oncotarget.2194","article-title":"The NF1 gene revisited - from bench to bedside","volume":"5","author":"Yap","year":"2014","journal-title":"Oncotarget"}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972122300040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S176972122300040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:53:52Z","timestamp":1761710032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S176972122300040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S176972122300040X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2023.104734","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French cohort of children and adolescents with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas: CASSIOPEA study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2023.104734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104734"}}